Photodynamic Diagnosis-Guided Ureteroscopic Laser Ablation for Urothelial Carcinoma
Author Information
Author(s): Yoshida Takashi MD, PhD, Motoki Yusuke MD, Rogers Craig G. MD, Raza Johar MD, Nakamoto Takahiro MD, Matsuda Tadashi MD, PhD, Kinoshita Hidefumi MD, PhD
Primary Institution: Kansai Medical University, Osaka, Japan
Hypothesis
Can photodynamic diagnosis (PDD) improve the efficacy and safety of ureteroscopic laser ablation for upper urinary tract urothelial carcinoma?
Conclusion
The study demonstrated that PDD-guided ureteroscopy significantly improved disease progression-free survival rates.
Supporting Evidence
- The study enrolled 20 patients, with 18 completing the trial.
- 2-year disease progression-free survival rate was 93.8%.
- 75% of patients had no recurrence at second-look ureteroscopy.
Takeaway
This study shows that a special light can help doctors find and remove cancer better during surgery.
Methodology
A single-arm, phase 2 trial evaluating PDD-guided ureteroscopy using oral 5-ALA in patients with upper urinary tract urothelial carcinoma.
Potential Biases
Potential bias due to the single-arm design and lack of a control group.
Limitations
The study had a limited sample size and was conducted at a single institution.
Participant Demographics
Patients aged 20 years and older with previously confirmed tumor grade.
Statistical Information
P-Value
0.05
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website